Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick F Lang

Showing results (81-90 of 251) with videos related to

Pageof 26
Sort By:
Journal of Proteome Research|February 3, 2007
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expressionMaja Puchades, Carol L Nilsson, Mark R Emmett, et al.
Journal of Neurosurgery|January 26, 2024
The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumorsIan F Parney, Ronald E Warnick, Frederick F Lang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastasesUgur Selek, Eric L Chang, Samuel J Hassenbusch, et al.
Journal of Neurosurgery|March 24, 2009
Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complicationsBrian J Williams, Dima Suki, Benjamin D Fox, et al.
Journal of Neuro-Oncology|December 6, 2006
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trialsSusan Chang, Michael Vogelbaum, Frederick F Lang, et al.
AJNR. American Journal of Neuroradiology|July 1, 2025
State of Practice: A Report from the Inaugural SNIS Neurointerventional Oncology SummitChristopher C Young, Kazim H Narsinh, Stephen R Chen, et al.
Neuro-Oncology|July 14, 2021
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stressPratibha Sharma, Jihong Xu, Katie Williams, et al.
Neuro-Oncology|April 29, 2017
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survivalTal Shahar, Uri Rozovski, Kenneth R Hess, et al.
Acta Neuropathologica|September 2, 2015
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaQun Liu, Yuexin Liu, Wenliang Li, et al.
Journal of Neurosurgery. Case Lessons|May 5, 2025
Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative caseEne Chibawanye I, Elizabeth Silva, Kyle Noll, et al.
Pageof 26

Showing results (81-90 of 251) with videos related to

Sort By:
Pageof 26
Journal of Proteome Research|February 3, 2007
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expressionMaja Puchades, Carol L Nilsson, Mark R Emmett, et al.
Journal of Neurosurgery|January 26, 2024
The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumorsIan F Parney, Ronald E Warnick, Frederick F Lang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastasesUgur Selek, Eric L Chang, Samuel J Hassenbusch, et al.
Journal of Neurosurgery|March 24, 2009
Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complicationsBrian J Williams, Dima Suki, Benjamin D Fox, et al.
Journal of Neuro-Oncology|December 6, 2006
GNOSIS: guidelines for neuro-oncology: standards for investigational studies--reporting of surgically based therapeutic clinical trialsSusan Chang, Michael Vogelbaum, Frederick F Lang, et al.
AJNR. American Journal of Neuroradiology|July 1, 2025
State of Practice: A Report from the Inaugural SNIS Neurointerventional Oncology SummitChristopher C Young, Kazim H Narsinh, Stephen R Chen, et al.
Neuro-Oncology|July 14, 2021
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stressPratibha Sharma, Jihong Xu, Katie Williams, et al.
Neuro-Oncology|April 29, 2017
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survivalTal Shahar, Uri Rozovski, Kenneth R Hess, et al.
Acta Neuropathologica|September 2, 2015
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaQun Liu, Yuexin Liu, Wenliang Li, et al.
Journal of Neurosurgery. Case Lessons|May 5, 2025
Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative caseEne Chibawanye I, Elizabeth Silva, Kyle Noll, et al.
Pageof 26